Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 287

1.

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.

Gislason GH, Rasmussen JN, Abildstrøm SZ, Gadsbøll N, Buch P, Friberg J, Rasmussen S, Køber L, Stender S, Madsen M, Torp-Pedersen C.

Eur Heart J. 2006 May;27(10):1153-8. Epub 2006 Jan 6.

PMID:
16399775
[PubMed - indexed for MEDLINE]
Free Article
2.

Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.

Lee HY, Cooke CE, Robertson TA.

J Manag Care Pharm. 2008 Apr;14(3):271-80.

PMID:
18439049
[PubMed - indexed for MEDLINE]
Free Article
3.

Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.

Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Buch P, Sørensen R, Folke F, Gadsbøll N, Rasmussen S, Køber L, Madsen M, Torp-Pedersen C.

Circulation. 2007 Aug 14;116(7):737-44. Epub 2007 Jul 23.

PMID:
17646585
[PubMed - indexed for MEDLINE]
Free Article
4.

Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.

Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.

Am Heart J. 2003 Mar;145(3):438-44.

PMID:
12660666
[PubMed - indexed for MEDLINE]
5.

Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.

Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.

Can J Cardiol. 2005 May 1;21(6):485-8.

PMID:
15917876
[PubMed - indexed for MEDLINE]
6.

Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.

van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.

Clin Ther. 2005 Nov;27(11):1806-14.

PMID:
16368451
[PubMed - indexed for MEDLINE]
7.

Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.

Austin PC, Tu JV, Ko DT, Alter DA.

CMAJ. 2008 Oct 21;179(9):901-8. doi: 10.1503/cmaj.080295.

PMID:
18936455
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Nationwide trends in the prescription of beta-blockers and angiotensin-converting enzyme inhibitors after myocardial infarction in Denmark, 1995-2002.

Gislason GH, Abildstrom SZ, Rasmussen JN, Rasmussen S, Buch P, Gustafsson I, Friberg J, Gadsbøll N, Køber L, Stender S, Madsen M, Torp-Pedersen C.

Scand Cardiovasc J. 2005 Apr;39(1-2):42-9.

PMID:
16097413
[PubMed - indexed for MEDLINE]
9.

Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.

Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC.

Am J Cardiol. 2007 Oct 1;100(7):1061-7. Epub 2007 Jul 30.

PMID:
17884362
[PubMed - indexed for MEDLINE]
10.

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.

Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.

Am J Med. 2004 Jul 15;117(2):73-81.

PMID:
15234641
[PubMed - indexed for MEDLINE]
11.

Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?

Hudson M, Richard H, Pilote L.

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):773-85.

PMID:
17486661
[PubMed - indexed for MEDLINE]
12.

Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.

Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.

J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):714-8. doi: 10.2459/JCM.0b013e32832c6110.

PMID:
19465867
[PubMed - indexed for MEDLINE]
13.

Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction.

Shlipak MG, Browner WS, Noguchi H, Massie B, Frances CD, McClellan M.

Am J Med. 2001 Apr 15;110(6):425-33.

PMID:
11331052
[PubMed - indexed for MEDLINE]
14.

The management of acute myocardial infarction--practical problems in implementing the evidence.

O'Neill JO, Nash PJ, Bourke W, McGarry K, Bedford D.

Ir Med J. 2002 Oct;95(9):270-2.

PMID:
12469997
[PubMed - indexed for MEDLINE]
15.

Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.

Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV; Canadian Cardiovascular Outcomes Research Team.

Can J Cardiol. 2004 Jan;20(1):61-7.

PMID:
14968144
[PubMed - indexed for MEDLINE]
16.

Effect of age on the use of evidence-based therapies for acute myocardial infarction.

Tran CT, Laupacis A, Mamdani MM, Tu JV.

Am Heart J. 2004 Nov;148(5):834-41.

PMID:
15523314
[PubMed - indexed for MEDLINE]
17.

Survival benefit of the late percutaneous coronary intervention in the patients after acute myocardial infarction who are or who are not treated with thrombolysis.

Knezević B, Bulatović N, Belada N, Ivanović V, Dragnić S, Rabrenović M, Nikolić G, Musić L, Bosković A.

Bosn J Basic Med Sci. 2009 Feb;9(1):54-8.

PMID:
19284396
[PubMed - indexed for MEDLINE]
18.

Use of evidence-based pharmacotherapy after myocardial infarction in Estonia.

Marandi T, Baburin A, Ainla T.

BMC Public Health. 2010 Jun 23;10:358. doi: 10.1186/1471-2458-10-358.

PMID:
20569449
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.

Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC; Korea Acute Myocardial Infarction Registry Investigators.

Am Heart J. 2010 Jun;159(6):1012-9. doi: 10.1016/j.ahj.2010.03.009.

PMID:
20569714
[PubMed - indexed for MEDLINE]
20.

[Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].

Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J; Investigadores del PRIAMHO II.

Rev Esp Cardiol. 2006 Apr;59(4):313-20. Spanish.

PMID:
16709383
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk